Skip to content
Screener

RxSight, Inc. RXST Q1 2025 earnings

Reported May 7, 2025 · After market close

Revenue$37.9MIn line
EPS-$0.03Beat by $0.01
Revenue estimate$37.9M
EPS estimate-$0.04

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$27.2M
EPS estimate-$0.29

Financials

Q1 2025

Income statement

See full
Revenue$37.9M+28.4%
Gross profit$28.3M+37.0%
Operating income-$10.7M0.0%
Net income-$8.2M+10.0%
EPS (diluted)-$0.20+20.0%

Balance sheet

See full
Cash & equivalents$28.0M-14.2%
Total debt$12.0M+377%
Total equity$279.3M+70.4%
Total assets$313.0M+70.9%

Cash flow

See full
Operating cash flow-$8.8M+5.1%
CapEx$575.0K-70.8%
Free cash flow-$9.4M+16.6%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$1.02B-46.2%
Enterprise value$1.01B-46.2%
P/S6.9×-11.9×

Profitability

See full
Gross margin71.9%+8.5pp
Operating margin-24.9%-8.0pp
Net margin-17.9%-6.7pp
FCF margin-13.8%-5.4pp

Returns & leverage

See full
Return on equity-12%-4.4pp
Debt / equity0×0.0×
Current ratio12.7×+3.5×

Segments

By product

See full
Rxlal$27.2M+36.5%
LDD$9.4M+7.8%
Service Warranty Service Contracts And Accessories$1.3M+49.5%

FAQ

When did RxSight, Inc. report Q1 2025 earnings?
RxSight, Inc. (RXST) reported Q1 2025 earnings on May 7, 2025 after market close.
What were RxSight, Inc.'s Q1 2025 revenue and EPS?
RxSight, Inc. reported revenue of $37.9M and eps of $-0.03 for Q1 2025.
Did RxSight, Inc. beat estimates in Q1 2025?
Revenue missed the consensus estimate of $37.9M by $11.3K. EPS beat the consensus estimate of $-0.04 by $0.01.
How did RxSight, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 28.4% from $29.5M a year earlier and eps grew 75.0% from $-0.12.
Where can I find RxSight, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-065655) and the 10-Q periodic report (0000950170-25-065683) directly on SEC EDGAR. The filing index links above go to sec.gov.